eli lilly phase 3 trial retatrutide TRIUMPH-4 Results: 28.7% Weight Loss & What It Means for the Peptide Industry Lilly orforglipron oral GLP-1 phase

Or which one fits my diagnosis better

The analysis results above indicate that DHRS7 may play a significant role in tumor progression, primarily through the biological processes described

1996;78 Suppl 1:1-24

While GLP-1R agonists have demonstrated cardiovascular benefits in clinical trials, including reduced rates of major adverse cardiovascular events (MACE) in T2DM patients, their antithrombotic efficacy is generally considered less potent than that of traditional antithrombotic agents

What Happens Physiologically When both peptides are administered simultaneously: Sermorelin primes the GHRH receptor on pituitary somatotrophs Ipamorelin activates the GHS receptor on the same cells The dual signal produces an amplified GH secretory pulse Somatostatin feedback remains intact, preventing excessive GH release IGF-1 levels rise gradually over days to weeks as the liver responds to increased GH Downstream benefits in tissue repair, metabolism, and sleep quality follow Sermorelin and Ipamorelin Together vs